Estimates and ranges used for the sensitivity analysis of the cost effectiveness of a universal screening programme for asymptomatic Chlamydia trachomatis infections in a female population
| Variable | Estimate (%) | Range | Domain | References |
|---|---|---|---|---|
| *Discounted in the model by the age specific desire for pregnancy. | ||||
| LCR = ligase chain reaction, PID = pelvic inflammatory disease. | ||||
| Prevalence | 2.9 | — | All women | Study data |
| Sensitivity LCR | 85 | 85–90 | Tested women | 9, 10 |
| Specificity LCR | 99 | — | Tested women | 8, 10 |
| Contacted for treatment | 90 | — | Women with chlamydia | Study data |
| Successfully treated | 95 | — | Women with chlamydia, who receive treatment | Study data |
| All PID | 10 | 5–25 | Women with undiagnosed or unsuccessfully treated infection | 4, 13 |
| Asymptomatic of total PID | 50 | — | All PID | 14 |
| Preventable PID | 50 | 25–75 | All PID | 14 |
| Infertility | 8 | 4–16 | All PID* | 1 |
| Ectopic pregnancy | 8 | 4–16 | All PID* | 1 |
| Chronic pelvic pain | 15 | 10–20 | All PID | 2 |
| Neonatal conjunctivitis | 30 | — | Women with chlamydia* | 3 |
| Neonatal pneumonia | 15 | — | Women with chlamydia* | 3 |